Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17,131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
C(H)OP refractory chronic lymphocytic leukemia patients in whom salvage chemotherapy chosen by evaluating multiple chemotherapeutic drug-resistant factors was remarkably effective.
Matsunaga T, Kogawa K, Fujimi A, Takizawa K, Takahira N, Takemoto N, Tanaka I, Akiyama T, Sato T, Takayama T, Terui T, Sakamaki S, Niitsu Y. Matsunaga T, et al. Among authors: sato t. Int J Clin Oncol. 2003 Oct;8(5):326-31. doi: 10.1007/s10147-003-0327-7. Int J Clin Oncol. 2003. PMID: 14586760
Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia.
Matsunaga T, Takemoto N, Sato T, Takimoto R, Tanaka I, Fujimi A, Akiyama T, Kuroda H, Kawano Y, Kobune M, Kato J, Hirayama Y, Sakamaki S, Kohda K, Miyake K, Niitsu Y. Matsunaga T, et al. Among authors: sato t. Nat Med. 2003 Sep;9(9):1158-65. doi: 10.1038/nm909. Epub 2003 Aug 3. Nat Med. 2003. PMID: 12897778 Free article.
Interleukin-11 as an osteoprotegerin-inducing factor in culture medium of blastic cells from a patient with acute megakaryocytic leukemia complicated with osteosclerosis.
Sato T, Matsunaga T, Kida M, Morii K, Machida T, Kawano Y, Nakamura K, Kuribayashi K, Takada K, Iyama S, Sato Y, Takayama T, Takahashi M, Kato J, Chokki M, Niitsu Y. Sato T, et al. Among authors: sato y. Am J Hematol. 2004 Sep;77(1):62-6. doi: 10.1002/ajh.20141. Am J Hematol. 2004. PMID: 15307108 Free article.
A phase I/II study of nedaplatin and 5-fluorouracil with concurrent radiotherapy in patients with esophageal cancer.
Sato Y, Takayama T, Sagawa T, Okamoto T, Miyanishi K, Sato T, Araki H, Iyama S, Abe S, Murase K, Takimoto R, Nagakura H, Hareyama M, Kato J, Niitsu Y. Sato Y, et al. Among authors: sato t. Cancer Chemother Pharmacol. 2006 Nov;58(5):570-6. doi: 10.1007/s00280-006-0193-x. Epub 2006 Feb 4. Cancer Chemother Pharmacol. 2006. PMID: 16463059 Clinical Trial.
17,131 results
You have reached the last available page of results. Please see the User Guide for more information.